Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Diabetic Medicine : a Journal of the British Diabetic Association|May 25, 2004
Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitusN H Kim, K B Kim, D L Kim, et al.
Diabetes, Obesity & Metabolism|January 13, 2015
Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extensionS-M Jin, C-Y Park, Y M Cho, et al.
Diabetes & Metabolism|October 11, 2020
Fasting plasma glucose variability in midlife and risk of Parkinson's disease: A nationwide population-based studyH S Chung, J S Lee, J A Kim, et al.
Diabetes Research and Clinical Practice|August 15, 2008
Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetesH J Yoo, H G An, S Y Park, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 21, 2010
Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathyS-H Ko, H-S Kwon, J-M Yu, et al.
Diabetes, Obesity & Metabolism|December 20, 2014
Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extensionS-M Jin, S W Park, K-H Yoon, et al.
Diabetes, Obesity & Metabolism|November 23, 2012
A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetesS J Yang, K W Min, S K Gupta, et al.
International Journal of Clinical Practice|January 23, 2013
Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetesY-C Hwang, M Kang, C W Ahn, et al.
Diabetes, Obesity & Metabolism|October 28, 2010
A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetesE J Rhee, W Y Lee, K H Yoon, et al.
Pageof 9